Articles | Pfizer CentreOne

What Trends Will Shape the Pharma and Biotech Industries in 2023?

From adapting to budget constraints to weathering ongoing supply chain challenges, our industry experts discuss the forces that are driving current changes across the pharma and biotech sectors and share their insights into what we can expect in the market in 2023.

Understanding the evolving trends in the complex biologics landscape

Tom Wilson, Contract Manufacturing Lead at Pfizer CentreOne shares his unique insights into what’s driving biotechs working with the next era of complex biologics to rely on expert contract development and manufacturing organizations (CDMOs).

Embracing Pharma 5.0 for a patient-centered future

Tom Wilson, Global Contract Manufacturing Lead at Pfizer CentreOne, shares his unique insight into the need for the pharma industry to truly embrace the Pharma 5.0 revolution to continue improving patients’ lives.

2024 forecast: As CDMOs come off pandemic's highs and lows, employment and funding hitches persist - Fierce Pharma

What opportunities and obstacles will there be for CDMOs in 2024? The contract development and manufacturing organization (CDMO) realm remains one of biopharma's buzziest fields following on from the COVID-19 era.

3 Trends Shaping Drug Development and Manufacturing Strategies

We explore the key trends shaping the development and manufacturing strategies across the pharmaceutical industry and discuss how strategic partnerships can help build a solid foundation for success.

Manufacturing Excellence is a Team Effort

Pfizer’s manufacturing excellence story can be likened to the sport of crew rowing, learn how the teamwork in rowing mirrors teamworking in pharmaceutical manufacturing.

Five Best Practices to Ensure Quality Active Pharmaceutical Ingredients

In this blog we’ll explore the five key measures pharma companies must take to ensure the highest quality supply of their APIs.

The essential steps in evaluating a pre-filled syringe system

Learn about the essential steps developers must take when evaluating a pre-filled syringe system.

Checklist: The commodities you’ll need when migrating a drug product presentation from vial to pre-filled syringe

When migrating a drug product from vial to PFS, the closure must be screened for suitable parts. Take a look at our blog and checklist detailing what commodities you’ll need and when.

Liposomes – Challenges and Opportunities

Liposome technologies have become an important part of the drug delivery armory, discover more about them.

Putting contract dose manufacturing trends under the spotlight

Contract dose manufacturers, including small-molecule and biologic outsourcing partners have had to respond rapidly in order to continue to meet customers’ rapidly shifting needs.

Uniting target product profile, regulatory partnering strategies are essential for sustainable product success

Drug sponsors know very well how essential it is to establish the TPP (Target Product Profile) of their prospective drug product as early as possible.

Insights & Resources